Meningococcal Vaccination

Vaccines help protect against all three serogroups (B, C, and Y) of meningococcal disease commonly seen in the United States:

  • Meningococcal conjugate vaccines (Menactra® and Menveo®)
  • Serogroup B meningococcal vaccines (Bexsero® and Trumenba®)

What Everyone Should Know about Meningococcal Vaccines

Information on Meningococcal Vaccine Recommendations
Q&A image

In addition to meningococcal conjugate vaccination, clinicians may choose to administer a serogroup B meningococcal vaccine to patients 16 through 23 years old. Get information about these vaccine recommendations.

Meningococcal Vaccination: Information for Healthcare Professionals

Vaccination Coverage

Related Pages
Page last reviewed: March 28, 2017